✦ LIBER ✦

Sa2039 Does Anti-TNF-Alpha Therapy Affect the Morphology of Crohn's Disease?

✍ Scribed by Schaeffer, David F.; Walsh, Joanna; Kirsch, Richard; Waterman, Matti; Silverberg, Mark S.; Riddell, Robert H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sa1910 Long Term Outcomes of Crohn's Dis

✍ Perera, Lilani P.; Zadvornova, Yelena; Binion, David G.; Guilday, Corinne; Stein 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Sa1229 Infliximab as Second Anti-TNF Age

✍ Jason E. Gonzaga; Yelena Zadvornova; Daniel J. Stein; Lilani P. Perera; Amar S. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

P.06.12 NUTRITIONAL EFFECTS OF ANTI-TNF-

✍ S. Mazzuoli; I. Addante; S. Fragnan; N. Regano; M. Rizzi; G. Leogrande; A. Di Mo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Anti-TNF antibody therapy in Crohn's dis

✍ Ricart, E.; Ordas, I.; Panes, J. 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 62 KB

PGI5 COST-EFFECTIVENESS OF NATALIZUMAB I

✍ S Panjabi; T Niecko; SL Hass; L Lacey; MD Spencer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

W1126 Cost-Effectiveness of Natalizumab

✍ Sands, Bruce E.; Wolf, Douglas C.; Panjabi, Sumeet; Niecko, Timothy; Hass, Steve 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB